Form 4: UTHR Director Gifts Shares, Ownership Shifts

United Therapeutics Director Christopher Causey reported gifting 450 shares of common stock, reducing his direct beneficial ownership to 4,190 shares.

Summary

• Christopher Causey, a Director at United Therapeutics Corp (UTHR), reported a transaction involving the company's common stock.
• On November 3, 2025, Mr. Causey disposed of 450 shares of common stock through a gift (Transaction Code 'G').
• The price per share for this transaction was $0.00, consistent with a gift.
• Following this transaction, Mr. Causey directly beneficially owns 4,190 shares of United Therapeutics Corp common stock.

Sentiment

Score: 5

Explanation: A routine insider transaction reporting a gift of shares, which is generally neutral for company fundamentals and does not indicate a change in operational performance or strategic direction.

Negatives

• Direct beneficial ownership of common stock by Director Christopher Causey decreased by 450 shares.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal direct impact on the company's valuation or operational performance from this individual transaction.

Key Dates

Keywords

United Therapeutics, UTHR, Form 4, Insider Transaction, Director, Stock Gift, Beneficial Ownership